Article: South African Medicines Control Council Approves Distribution Of Diflucan Tablet For Oesophageal Candidiasis.

South African Diflucan Partnership Programme Prepares

To Distribute Antifungal Medicine to HIV/AIDS Patients

Pretoria, SOUTH AFRICA, Feb 20 /PRNewswire/ --

The following press release was issued this morning in South Africa:

The South African Ministry of Health announced today that the South African Medicines Control Council (MCC) has granted approval for distribution of a tablet form of Pfizer Inc.'s antifungal medicine Diflucan for the treatment of oesophageal candidiasis. Diflucan is already an approved treatment for cryptococcal meningitis in South Africa.

The Ministry of Health and Pfizer said that, on news of the MCC ...

Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!